M.G. Finn

Mark Prausnitz is director of the Center for Drug Design, Development and Delivery at Georgia Tech. He works on something called microneedle patches to deliver vaccines. So far, he's developed patch vaccines for flu and measles, but the technology could be used for a COVID-19 vaccine as well.

RNA-based drugs have the potential to change the standard of care for many diseases, making personalized medicine a reality. This rapidly expanding class of therapeutics are cost-effective, fairly easy to manufacture, and able to go where no drug has gone before, reaching previously undruggable pathways.

For skin care like a cetacean, you’re going to need corals, sponges and the ability to hold your breath for a long time.

A structure that links amino acids suggests that early organisms could have been based on an RNA-protein mix

Woon-Hong Yeo

The gel, which was implanted alongside a pancreatic cell transplant in monkeys with type 1 diabetes, releases a protein that kills overactive immune cells, preventing the pancreatic cells from being rejected

Nicoleta Serban

Pinar Keskinocak

Pinar Keskinocak